Title : Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling of cetagliptin in patients with type 2 diabetes mellitus - Zhou_2024_Front.Endocrinol.(Lausanne)_15_1359407 |
Author(s) : Zhou C , Zhou S , Wang J , Xie L , Lv Z , Zhao Y , Wang L , Luo H , Xie D , Shao F |
Ref : Front Endocrinol (Lausanne) , 15 :1359407 , 2024 |
Abstract : Zhou_2024_Front.Endocrinol.(Lausanne)_15_1359407 |
ESTHER : Zhou_2024_Front.Endocrinol.(Lausanne)_15_1359407 |
PubMedSearch : Zhou_2024_Front.Endocrinol.(Lausanne)_15_1359407 |
PubMedID: 38529396 |
Zhou C, Zhou S, Wang J, Xie L, Lv Z, Zhao Y, Wang L, Luo H, Xie D, Shao F (2024)
Safety, tolerability, pharmacokinetics and pharmacokinetic-pharmacodynamic modeling of cetagliptin in patients with type 2 diabetes mellitus
Front Endocrinol (Lausanne)
15 :1359407
Zhou C, Zhou S, Wang J, Xie L, Lv Z, Zhao Y, Wang L, Luo H, Xie D, Shao F (2024)
Front Endocrinol (Lausanne)
15 :1359407